True enough. We should be getting some news of some kind soon, anyway. The trial in England is set to start (get approval?) in December. Maybe the company will at least give an informal summary of the Neuroscience at the meeting tomorrow.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.